For patients with metastatic castration-sensitive prostate cancer (mCSPC) with homologous recombination repair (HRR) gene ...
A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...
Biotech clinical laboratories are at the center of new medical discoveries, using tools like molecular biology and genetics ...
Long interspersed nuclear element-1 (LINE-1 or L1) is the only active, self-copying genetic element in the human ...
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Channing Paller discussing germline and somatic genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback